Konskie

Pain management following total hip replacement surgery is crucial for patient recovery and comfort. This trial examines the safety and effectiveness of various doses of morphine administered directly into the spinal sac during spinal anesthesia. Morphine, known for its long-lasting pain relief effects up to 24 hours, can also cause serious side effects like respiratory depression, making precise dosing essential to balance benefits and risks. This is a Phase 4 study focused on assessing different morphine doses for pain control after hip replacement surgery. Participants receive spinal anesthesia using bupivacaine administered via a needle into the spinal area while seated. Along with morphine dosing, patients receive preemptive analgesics including paracetamol and metamizole before surgery. After surgery, pain management includes scheduled doses of acetaminophen, dexketoprofen, and metamizole intravenously. Patients are also provided with a patient-controlled analgesia (PCA) syringe pump containing oxycodone to manage breakthrough pain, with thorough instruction on its use. During the 48 hours after surgery, patients are closely monitored with continuous vital sign tracking using patient monitors. Researchers evaluate the pain relief effectiveness and safety profile of the morphine doses within this period. The study measures outcomes such as analgesic effectiveness and any adverse effects to ensure safe pain control after hip replacement surgery.